Rethinking Vaginal Health: Engineering Hydrogels That Work With the Microbiome
Share
By Prof Catherine Tuleu, Professor of Paediatric Pharmaceutics at University College London (UCL) and Scientific Advisor to BiotaLife Healthcare, providing independent scientific guidance, without receiving any payment or incentive from BiotaLife

For decades, pharmaceutical research into women’s intimate health has operated under a flawed paradigm: treating infection by eradicating the microenvironment. Whether through broad-spectrum antimicrobials or acidifying agents, traditional treatments often act indiscriminately, disrupting the vaginal microbiome and driving the high recurrence rates seen in bacterial vaginosis (BV) and vulvovaginal candidiasis (thrush).¹
As a formulation researcher based in London, translating smart drug delivery systems into real-world therapeutic impact is central to what I do. Moving BiotaLife Healthcare’s headquarters to London has placed us at the heart of a thriving life sciences ecosystem, enabling close translational collaboration with King’s College London and UCL. From a pharmaceutical perspective, our goal is clear: stop destroying the vaginal ecosystem and start engineering platforms that help it heal itself.

The Rheological Precision Behind DuoBalance™
Treating dysbiosis requires precise delivery mechanics. DuoBalance™, our candidate medical device hydrogel now advancing into clinical trials, relies on a carefully optimised polymeric matrix (utilising HPMC, sodium alginate, and croscarmellose sodium).
- Targeted Prebiotic Action: Rather than introducing external probiotics or harsh acids,² the hydrogel delivers neutral glycogen to selectively nourish native Lactobacillus species, restoring physiological pH naturally without localized irritation.
- Shear-Thinning & Mucoadhesion: Engineered using Quality-by-Design (QbD) principles but with women’s comfort in mind, the hydrogel exhibits pseudoplastic, shear-thinning behaviour for smooth application alongside strong mucoadhesion. This ensures controlled, sustained release over four few hours, staying in place to displace pathogens like GBS, Candida, and BV-associated bacteria and support the good Lactobacillus bacteria to thrive.
BloomCalma™: Life-Stage Architecture for Real-World Care
Formulation design must also adapt to the physiological realities of a woman’s life. During pregnancy and postpartum recovery, the tvulva and perineum experiences extreme sensitivity and hormonal shifts where harsh clinical gels fail.
Part of our broader life-stage product range, BloomCalma applies this same microbiome-first formulation philosophy to everyday antenatal and perinatal intimate care . Designed to soothe and nourish external delicate tissues without disrupting native flora, it offers a gentle, non-irritating alternative that respects the body's natural balance.
By combining academic rigor, targeted polymer engineering, and a deep respect for women’s physiological stages, BiotaLife is redefining the standard of intimate healthcare, moving away from temporary fixes toward true biological restoration.
References
- Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. The Lancet Infectious Diseases. 2018;18(11):e339-e347. https://doi.org/10.1016/S1473-3099(18)30103-8
- Tyssen D, Hearps AC, Guntur K, et al. The impact of over-the-counter lactic acid containing vaginal gels on the integrity and inflammatory state of the vaginal epithelium in vitro. Frontiers in Reproductive Health. 2022;4:915948. https://doi.org/10.3389/frph.2022.915948
FAQ
What is a vaginal hydrogel?
A vaginal hydrogel is a water-based gel made from polymers that hold moisture and spread over delicate tissue. In intimate health, hydrogels are used to deliver active ingredients exactly where they are needed. How the polymers are chosen and combined decides how the gel feels, how long it stays in place and how it interacts with the vaginal microbiome.
Why can acidic vaginal gels cause irritation?
Many over-the-counter vaginal gels use lactic acid to lower pH. A 2022 laboratory study of 11 such gels found that most were far more concentrated than healthy vaginal fluid, and several damaged the vaginal lining and triggered inflammation in tissue models. This is one reason BiotaLife designs acid-free formulations.
What is a prebiotic, and why use glycogen?
A prebiotic feeds the beneficial bacteria already present, while a probiotic adds new bacteria from outside. Glycogen is a sugar stored in the cells lining the vagina. Lactobacillus species use it to produce lactic acid, which keeps vaginal pH low. DuoBalance is designed to supply glycogen to support a woman's own Lactobacillus populations.
What is mucoadhesion, and why does it matter?
Mucoadhesion is the ability of a gel to stick to the moist mucosal lining. A mucoadhesive gel stays in contact with tissue for longer instead of leaking away, which supports more consistent delivery and better comfort. It is one of the key properties Prof Catherine Tuleu's team optimised in the DuoBalance hydrogel.
What does shear thinning mean in an intimate gel?
A shear thinning gel becomes more fluid when pressure is applied, for example when it is squeezed from a tube or spread, then thickens again once it is at rest. This allows smooth, comfortable application while helping the gel stay where it is placed.
How is DuoBalance designed?
DuoBalance™ is a patented, antibiotic-free and acid-free candidate medical device being developed by BiotaLife Healthcare. It is a mucoadhesive hydrogel built from HPMC, sodium alginate and croscarmellose sodium, designed to deliver glycogen that supports native Lactobacillus species. It is now advancing into clinical trials and is not yet approved or available to buy.
How is BloomCalma different from DuoBalance?
BloomCalma™ is a cosmetic, pH-balanced intimate moisturising gel for pregnancy and postpartum, for external use only. It is designed for perineal massage and intimate comfort. DuoBalance is a candidate medical device for BV and thrush now advancing into clinical trials. Both follow the same microbiome-first formulation approach, but they serve different needs.
Who is Prof Catherine Tuleu?
Prof Catherine Tuleu is Professor of Pharmaceutics at UCL School of Pharmacy and Scientific Advisor to BiotaLife Healthcare. Her research focuses on formulation and drug delivery, translating laboratory science into products designed around the people who use them. She advises BiotaLife on hydrogel design for its intimate health range.